Reference Identification

Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritis.

Ann Rheum Dis, Nell‐Duxneuner VP, Stamm TA, Machold KP, Pflugbeil S, Aletaha D, Smolen JS. dis 2010; 69:
Country: Austria
Language: English

Other references of interest

https://pubmed.ncbi.nlm.nih.gov/19762363/

The objective of this study was to identify instruments best reflecting disease activity in PsA.

https://pubmed.ncbi.nlm.nih.gov/26471734/

Summary of some important properties of the DAPSA.

https://pubmed.ncbi.nlm.nih.gov/27457512/

This study concludes that disease activity states of the DAPSA score are valid for future use as endpoints in clinical trials or as targets in clinical practice.

Instrument/Tool Translations References

Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofacitinib studies. 

https://pubmed.ncbi.nlm.nih.gov/36476498/